Published in Cell Tissue Res on July 01, 2000
A point mutation of Tyr-759 in interleukin 6 family cytokine receptor subunit gp130 causes autoimmune arthritis. J Exp Med (2002) 1.57
Adoptive immunotherapy of cancer with polyclonal, 108-fold hyperexpanded, CD4+ and CD8+ T cells. J Transl Med (2004) 1.02
Impaired CD4+ T-cell proliferation and effector function correlates with repressive histone methylation events in a mouse model of severe sepsis. Eur J Immunol (2010) 0.96
Galectin-8 induces apoptosis in Jurkat T cells by phosphatidic acid-mediated ERK1/2 activation supported by protein kinase A down-regulation. J Biol Chem (2009) 0.90
Characterization of avian γδ T-cell subsets after Salmonella enterica serovar Typhimurium infection of chicks. Infect Immun (2010) 0.88
Apoptosis and the balance of homeostatic and pathologic responses to protozoan infection. Infect Immun (2003) 0.86
The adenovirus e3 promoter is sensitive to activation signals in human T cells. J Virol (2003) 0.85
Death pathways in T cell homeostasis and their role in autoimmune diabetes. Rev Diabet Stud (2006) 0.85
Immunotherapy for solid tumors--a review for surgeons. J Surg Res (2013) 0.83
Fas ligand is required for the development of respiratory syncytial virus vaccine-enhanced disease. J Immunol (2009) 0.77
Dietary n-3 PUFAs augment caspase 8 activation in Staphylococcal aureus enterotoxin B stimulated T-cells. Toxicol Appl Pharmacol (2016) 0.75
Proliferation and apoptosis of peripheral blood mononuclear cells in patients with oral lichen planus. Inflammation (2013) 0.75
Human T-cell receptor variable gene segment families. Immunogenetics (1995) 2.86
Mouse T-cell receptor variable gene segment families. Immunogenetics (1995) 2.24
Appearance of anti-HLA-DR-reactive cells in normal and rheumatoid synovial tissue. Scand J Immunol (1981) 2.02
Evidence in support of a self-perpetuating HLA-DR-dependent delayed-type cell reaction in rheumatoid arthritis. Proc Natl Acad Sci U S A (1982) 1.99
Induction of activation-driven death (apoptosis) in activated but not resting peripheral blood T cells. J Immunol (1993) 1.81
T cell receptor/CD3-signaling induces death by apoptosis in human T cell receptor gamma delta + T cells. J Immunol (1991) 1.45
Intradecidual T lymphocytes lack immunohistochemically detectable T-cell receptors. Am J Reprod Immunol (1990) 1.39
A rapid colorimetric assay for the determination of IL-2-producing helper T cell frequencies. J Immunol Methods (1985) 1.33
Lysis of a broad range of epithelial tumour cells by human gamma delta T cells: involvement of NKG2D ligands and T-cell receptor- versus NKG2D-dependent recognition. Scand J Immunol (2007) 1.32
Staurosporine and conventional anticancer drugs induce overlapping, yet distinct pathways of apoptosis and caspase activation. Oncogene (2001) 1.29
Immune functions of human synovial cells. Phenotypic and T cell regulatory properties of macrophage-like cells that express HLA-DR. Arthritis Rheum (1982) 1.29
Generation of soluble NKG2D ligands: proteolytic cleavage, exosome secretion and functional implications. Scand J Immunol (2013) 1.24
Primary activation of V gamma 9-expressing gamma delta T cells by Mycobacterium tuberculosis. Requirement for Th1-type CD4 T cell help and inhibition by IL-10. J Immunol (1994) 1.15
Differentiation of resting human peripheral blood gamma delta T cells toward Th1- or Th2-phenotype. Cell Immunol (2001) 1.13
Tumor necrosis factor selectively inhibits activation of human B cells by Epstein-Barr virus. J Immunol (1988) 1.12
FasL:Fas ratio--a prognostic factor in breast carcinomas. Cancer Res (2000) 1.10
Comparison of human and mouse T-cell receptor variable gene segment subfamilies. Immunogenetics (1995) 1.02
Toll-like receptor expression and function in subsets of human gammadelta T lymphocytes. Scand J Immunol (2009) 1.02
SLP-76 binding to p56lck: a role for SLP-76 in CD4-induced desensitization of the TCR/CD3 signaling complex. J Immunol (1999) 1.01
T cell receptor gamma delta repertoire in HIV-1-infected individuals. Eur J Immunol (1994) 1.00
Mycobacteria-reactive gamma delta T cells in HIV-infected individuals: lack of V gamma 9 cell responsiveness is due to deficiency of antigen-specific CD4 T helper type 1 cells. Eur J Immunol (1996) 0.99
CD4-CD8- human T cells: phenotypic heterogeneity and activation requirements of freshly isolated "double-negative" T cells. Cell Immunol (1990) 0.99
Comparative analysis of alpha beta and gamma delta T cell activation by Mycobacterium tuberculosis and isopentenyl pyrophosphate. Eur J Immunol (1997) 0.98
Rapid quantification of lymphocyte subsets in heterogeneous cell populations by flow cytometry. Cytometry (1994) 0.97
In vitro effects of mistletoe extracts and mistletoe lectins. Cytotoxicity towards tumor cells due to the induction of programmed cell death (apoptosis). Arzneimittelforschung (1993) 0.96
Selective reduction of donor-specific cytotoxic T lymphocyte precursors in patients with a well-functioning kidney allograft. Transplantation (1987) 0.95
Gamma/delta T lymphocytes and heat shock proteins. Curr Top Microbiol Immunol (1991) 0.94
Human cytotoxic T lymphocytes. I. Limiting-dilution analysis of alloreactive cytotoxic T-lymphocyte precursor frequencies. Scand J Immunol (1985) 0.94
Activation-driven death of human T cell clones: time course kinetics of the induction of cell shrinkage, DNA fragmentation, and cell death. Cell Immunol (1993) 0.94
Sensitization to death receptor cytotoxicity by inhibition of fas-associated death domain protein (FADD)/caspase signaling. Requirement of cell cycle progression. J Biol Chem (2000) 0.93
Ex vivo induction of apoptosis in lymphocytes is mediated by oxidative stress: role for lymphocyte loss in HIV infection. Free Radic Biol Med (1997) 0.93
Triggering via the alternative CD2 pathway induces apoptosis in activated human T lymphocytes. Eur J Immunol (1993) 0.91
An optimized method for the functional analysis of human regulatory T cells. Scand J Immunol (2006) 0.90
V delta repertoire during thymic ontogeny suggests three novel waves of gamma delta TCR expression. J Immunol (2000) 0.90
Activation of human T lymphocytes by 12-O-tetradecanoylphorbol-13-acetate: role of accessory cells and interaction with lectins and allogeneic cells. Cell Immunol (1982) 0.90
Expression of the apoptosis-inducing ligands FasL and TRAIL in malignant and benign human breast tumors. Histochem Cell Biol (2000) 0.89
CD95 ligand--death factor and costimulatory molecule? Cell Death Differ (2003) 0.89
Modulation of CD4+ T-cell activation by CD95 co-stimulation. Cell Death Differ (2010) 0.88
Induction of TCR-gamma delta expression on triple-negative (CD3-4-8-) human thymocytes. Comparative analysis of the effects of IL-4 and IL-7. J Immunol (1995) 0.88
Synovial fibroblasts as accessory cells for staphylococcal enterotoxin-mediated T-cell activation. Immunology (1995) 0.88
Anti-Ia-reactive cells in mycosis fungoides: a study of skin biopsies, single epidermal cells and circulating T lymphocytes. Acta Derm Venereol (1981) 0.87
Alloreactivity and apoptosis in graft rejection and transplantation tolerance. J Leukoc Biol (2000) 0.86
Inhibition of protein synthesis by the T cell receptor-inducible human TDAG51 gene product. Cell Signal (2001) 0.86
Density distribution profiles of T cells: TM, TG and TA cells and response patterns in autologous versus allogeneic MLRs. Scand J Immunol (1982) 0.86
Multiple interactions of the cytosolic polyproline region of the CD95 ligand: hints for the reverse signal transduction capacity of a death factor. FEBS Lett (2001) 0.85
Immunoregulatory effects of the herba Epimediia glycoside icariin. Arzneimittelforschung (1995) 0.85
Identification of the complete expressed human TCR V gamma repertoire by flow cytometry. Int Immunol (1997) 0.84
Detection of the 4977 bp deletion of mitochondrial DNA in different human blood cells. Exp Gerontol (2004) 0.84
Increase in Vdelta1+ gammadelta T cells in the peripheral blood and bone marrow as a selective feature of HIV-1 but not other virus infections. Br J Haematol (1998) 0.84
Regulation of T-cell death-associated gene 51 (TDAG51) expression in human T-cells. Cell Death Differ (2004) 0.84
B cell maturation in chronic lymphocytic leukemia. II. Clonal heterogeneity in the response to various B cell activators and recombinant cytokines (rIFN-gamma, rIFN-alpha, rIL2). Immunobiology (1987) 0.84
Clonal specificity of human gamma delta T cells: V gamma 9+ T-cell clones frequently recognize Plasmodium falciparum merozoites, Mycobacterium tuberculosis, and group-A streptococci. Int Arch Allergy Immunol (1993) 0.83
Markers of operational immune tolerance after pediatric liver transplantation in patients under immunosuppression. Pediatr Transplant (2013) 0.83
V gamma gene usage in peripheral blood gamma delta T cells. Immunol Lett (1993) 0.83
Stimulation of the specific immune system by mistletoe extracts. Anticancer Drugs (1997) 0.83
Interleukin-4 augments production of the third complement component by the alveolar epithelial cell line A549. Int Arch Allergy Immunol (1993) 0.83
Antigen-presenting T cells. II. Clonal responses of alloreactive and virus-specific self-restricted human cytotoxic T cell responses stimulated by T lymphoblasts. J Immunol (1987) 0.83
Surface expression of functional T cell receptor chains formed by interlocus recombination on human T lymphocytes. J Exp Med (1994) 0.83
Activation of human gamma delta T-cells by heat-treated mistletoe plant extracts. Immunol Lett (1996) 0.82
The decidua of early human pregnancy: immunohistochemistry and function of immunocompetent cells. Gynecol Obstet Invest (1992) 0.82
Inhibition of autologous mixed lymphocyte reaction by aggregated IgG molecules. Eur J Immunol (1982) 0.82
Decreased function of monocytes and granulocytes during HIV-1 infection correlates with CD4 cell counts. Eur J Med Res (1995) 0.82
Immunosuppression by OKT3--induction of programmed cell death (apoptosis) as a possible mechanism of action. Transplantation (1992) 0.82
Apoptosis: potential for disease therapies. Immunol Today (1998) 0.82
TNF-alpha mediated apoptosis of CD4 positive T-lymphocytes. A model of T-cell depletion in HIV infected individuals. Eur J Med Res (1996) 0.82
Phorbol ester-induced differentiation of chronic B lymphocytic leukaemia cells--regulatory impact of autologous and allogeneic accessory cells. Clin Exp Immunol (1985) 0.81
Synovial fibroblasts as target cells for staphylococcal enterotoxin-induced T-cell cytotoxicity. Immunology (1998) 0.81
Density separation of chronic lymphocytic leukemia cells: low-density non-T cells are efficient stimulator cells in allogeneic and autologous mixed leukocyte reaction. Clin Immunol Immunopathol (1983) 0.81
Tubular epithelial cells as accessory cells for superantigen-induced T cell activation. Exp Nephrol (1998) 0.81
Activation-induced T cell death: resistance or susceptibility correlate with cell surface fas ligand expression and T helper phenotype. Cell Immunol (1997) 0.81
Preferential activation of peripheral blood V gamma 9+ gamma/delta T cells by group A, B and C but not group D or F streptococci. Clin Exp Immunol (1992) 0.81
Recombinant interleukin 2 rapidly augments human natural killer cell activity. Cell Immunol (1985) 0.81
Monocyte-dependent death of freshly isolated T lymphocytes: induction by phorbolester and mitogens and differential effects of catalase. J Immunol (1998) 0.81
Adverse effects of intradermal allogeneic lymphocyte immunotherapy: acute reactions and role of autoimmunity. Hum Reprod (2005) 0.81
Activation of human gamma delta T cells by Mycobacterium tuberculosis and Daudi lymphoma cells: differential regulatory effect of IL-10 and IL-12. J Immunol (1997) 0.80
Analysis of the TCR Vgamma repertoire in healthy donors and HIV-1-infected individuals. Int Immunol (1998) 0.80
Selective activation of gamma/delta + T cell clones by single anti-CD2 antibodies. J Exp Med (1991) 0.79
Induction of cell death via Fas (CD95, Apo-1) may be associated with but is not dependent on Fas-induced tyrosine phosphorylation. Immunol Lett (1996) 0.79
Aminobisphosphonates and Toll-like receptor ligands: recruiting Vγ9Vδ2 T cells for the treatment of hematologic malignancy. Curr Med Chem (2011) 0.79
Quantitative assessment of interleukin-2-producing alloreactive human T cells by limiting dilution analysis. J Immunol Methods (1988) 0.79
Limiting dilution analysis: a new approach to study allograft acceptance. Transplant Proc (1987) 0.79
Phorbolester-treated human lymphocytes are susceptible to natural killer cell-mediated cytolysis. J Immunol (1983) 0.79
Clonal activation of cytotoxic lymphocyte precursors by monoclonal anti-CD3 antibody: analysis of feeder cell requirements. Immunol Lett (1987) 0.79
Modulation of natural killing by tumor promoters: the regulatory influence of adherent cells varies with the type of target cell. Immunobiology (1985) 0.79
Evidence that functional deletion of donor-reactive T lymphocytes in kidney allograft recipients can occur at the level of cytotoxic T cells, IL-2-producing T cells, or both. A limiting dilution study. Transplantation (1993) 0.79
Differential regulation of activation-induced cell death in individual human T cell clones. Int Arch Allergy Immunol (2000) 0.79
FasL expression and reverse signalling. Results Probl Cell Differ (2009) 0.78
Frequency analysis of allergen-reactive T-lymphocytes in individuals allergic against the house-dust mite Dermatophagoides pteronyssinus. Int Arch Allergy Immunol (1992) 0.78
Inhibition of human γδ T cell proliferation and effector functions by neutrophil serine proteases. Scand J Immunol (2014) 0.78
Dual TCR-expressing T lymphocytes in health and disease. Int Arch Allergy Immunol (2001) 0.78
Clonal expansion of gamma delta T cells expressing two distinct T-cell receptors. Br J Haematol (1996) 0.78
Human gammadelta T cells produce the protease inhibitor and antimicrobial peptide elafin. Scand J Immunol (2009) 0.78
Differential effects of interleukin-7 and interleukin-2 on T-cell receptor gamma delta-expressing cells within CD4-CD8- postnatal human thymocytes. Int Arch Allergy Immunol (1993) 0.77
Ligation of cell surface CD4 inhibits activation-induced death of human T lymphocytes at the level of Fas ligand expression. J Immunol (1997) 0.77
Human cytotoxic T lymphocytes. II. Frequency analysis of cyclosporin A-sensitive alloreactive cytotoxic T-lymphocyte precursors. Immunology (1987) 0.77